Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

21 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Pharmacokinetics of flecainide in patients with cirrhosis of the liver.
McQuinn RL, Pentikäinen PJ, Chang SF, Conard GJ. McQuinn RL, et al. Among authors: conard gj. Clin Pharmacol Ther. 1988 Nov;44(5):566-72. doi: 10.1038/clpt.1988.195. Clin Pharmacol Ther. 1988. PMID: 3141098
Plasma concentrations of flecainide acetate, a new antiarrhythmic agent, in humans.
Conard GJ, Carlson GL, Frost JW, Ober RE, Leon AS, Hunninghake DB. Conard GJ, et al. Clin Ther. 1984;6(5):643-52. Clin Ther. 1984. PMID: 6478470
The effect of flecainide acetate, a new antiarrhythmic, on plasma digoxin levels.
Weeks CE, Conard GJ, Kvam DC, Fox JM, Chang SF, Paone RP, Lewis GP. Weeks CE, et al. Among authors: conard gj. J Clin Pharmacol. 1986 Jan;26(1):27-31. doi: 10.1002/j.1552-4604.1986.tb02898.x. J Clin Pharmacol. 1986. PMID: 3950050
Flecainide pharmacokinetics after multiple dosing in patients with impaired renal function.
Forland SC, Cutler RE, McQuinn RL, Kvam DC, Miller AM, Conard GJ, Parish S. Forland SC, et al. Among authors: conard gj. J Clin Pharmacol. 1988 Aug;28(8):727-35. doi: 10.1002/j.1552-4604.1988.tb03207.x. J Clin Pharmacol. 1988. PMID: 3145942
The development and testing of intravenous dosing regimens: application to flecainide for the suppression of ventricular arrhythmias.
Wang T, Siddoway LA, Thompson KA, Conard GJ, Bergstrand RH, Kvam D, Roden DM, Woosley RL. Wang T, et al. Among authors: conard gj. Clin Pharmacol Ther. 1988 May;43(5):499-508. doi: 10.1038/clpt.1988.65. Clin Pharmacol Ther. 1988. PMID: 3130211
Oral flecainide pharmacokinetics in patients with impaired renal function.
Forland SC, Burgess E, Blair AD, Cutler RE, Kvam DC, Weeks CE, Fox JM, Conard GJ. Forland SC, et al. Among authors: conard gj. J Clin Pharmacol. 1988 Mar;28(3):259-67. doi: 10.1002/j.1552-4604.1988.tb03142.x. J Clin Pharmacol. 1988. PMID: 3129455
Identification of drug interactions by meta-analysis of premarketing trials: the effect of smoking on the pharmacokinetics and dosage requirements for flecainide acetate.
Holtzman JL, Weeks CE, Kvam DC, Berry DA, Mottonen L, Ekholm BP, Chang SF, Conard GJ. Holtzman JL, et al. Among authors: conard gj. Clin Pharmacol Ther. 1989 Jul;46(1):1-8. doi: 10.1038/clpt.1989.99. Clin Pharmacol Ther. 1989. PMID: 2501055 Clinical Trial. No abstract available.
The pharmacodynamic and pharmacokinetic interaction of flecainide acetate with propranolol: effects on cardiac function and drug clearance.
Holtzman JL, Kvam DC, Berry DA, Mottonen L, Borrell G, Harrison LI, Conard GJ. Holtzman JL, et al. Among authors: conard gj. Eur J Clin Pharmacol. 1987;33(1):97-9. doi: 10.1007/BF00610389. Eur J Clin Pharmacol. 1987. PMID: 3121353 No abstract available.
Biotransformation and elimination of 14C-flecainide acetate in humans.
McQuinn RL, Quarfoth GJ, Johnson JD, Banitt EH, Pathre SV, Chang SF, Ober RE, Conard GJ. McQuinn RL, et al. Among authors: conard gj. Drug Metab Dispos. 1984 Jul-Aug;12(4):414-20. Drug Metab Dispos. 1984. PMID: 6148206
Metabolism of flecainide.
Conard GJ, Ober RE. Conard GJ, et al. Am J Cardiol. 1984 Feb 27;53(5):41B-51B. doi: 10.1016/0002-9149(84)90501-0. Am J Cardiol. 1984. PMID: 6364769 Review.
21 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback